
Modicus Prime provides pharmaceutical manufacturers with GxP-compatible AI software that makes quality control auditable and compliant by design. The platform is a B2B SaaS framework that enables real-time AI model training, deployment, and continuous monitoring for biologics manufacturing and pharmaceutical quality assurance. It uses AI and machine learning with cloud-based real-time data processing, self-service AI training, and GxP/ISO compliance features to support researchers, data scientists, and production teams. The software includes automated alerts and audit-ready logs to detect morphology issues and contamination across R&D, process development, and commercial manufacturing. Modicus Prime targets pharmaceutical and life-sciences companies and contract development and manufacturing organizations (CDMOs) seeking to operationalize compliant AI for quality and cost improvements.

Modicus Prime provides pharmaceutical manufacturers with GxP-compatible AI software that makes quality control auditable and compliant by design. The platform is a B2B SaaS framework that enables real-time AI model training, deployment, and continuous monitoring for biologics manufacturing and pharmaceutical quality assurance. It uses AI and machine learning with cloud-based real-time data processing, self-service AI training, and GxP/ISO compliance features to support researchers, data scientists, and production teams. The software includes automated alerts and audit-ready logs to detect morphology issues and contamination across R&D, process development, and commercial manufacturing. Modicus Prime targets pharmaceutical and life-sciences companies and contract development and manufacturing organizations (CDMOs) seeking to operationalize compliant AI for quality and cost improvements.
Product: mpVision — GxP-compatible AI/computer-vision platform for biologics image analysis and quality control
Market focus: Pharmaceutical R&D and regulated biologics manufacturing
Funding (latest): Seed round announced Jul 15, 2024 (lead: Silverton Partners)
Founded: 2020
Team size: ~17 employees
| Company |
|---|
Quality assurance and image-based inspection in biologics R&D, process development, and commercial manufacturing under regulated GxP environments.
2020
Pharmaceutical Manufacturing
1100000
Pre-seed round closed Dec 31, 2022 with strategic investors including Alumni Ventures, Valor Ventures, SmartGateVC, Flywheel Fund, Techstars, PlugandPlay, Dotmatics
3500000
Seed round announced Jul 15, 2024 with participation from Alumni Ventures and others
“Venture-backed with participation from Silverton Partners, Alumni Ventures, and multiple strategic/accelerator investors”